Skip to content

Effect of Neuromuscular Electrical Stimulation of Quadriceps Femoris and Tibialis Anterior in Children with Spastic Cerebral Palsy : A Pilot Study

Effect of Electrical Stimulation in Children with Cerebral Palsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/11/003128
Enrollment
10
Registered
2012-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Spastic Cerebral Palsy (hemiplegic/ diplegic)

Interventions

Intervention1: Neuromuscular electrical stimulation (NMES) along with physiotherapy/occupational therapy: The subjects will recieve neuromuscular electrical stimulation (NMES) to quadriceps femoris

Sponsors

Indian Institute of Technology IIT Kharagpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Spastic diplegic or spastic hemiplegic cerebral palsy. 2) Seizure free or under control. 3) GMFCS level 2 and 3. 4) Children cooperative and tolerant to machine and intervention. 5) Parents motivated and willing. 6) Orthopaedic: a) At least 1 year since soft tissue or bone surgery. b) No significant skeletal abnormality such as scoliosis. c) At least 6 months post BOTOX. 7) Range Of Movements (ROM) a) Less than 10 degree Hip flexion contracture. b) Less than 20 degree Hip abduction deformity. c) Less than 5 degree Knee flexion contracture. d) Greater than 45 degree popliteal angle. e) Angle dorsiflexion to neutral with knee extended.

Exclusion criteria

Exclusion criteria: 1) Seizure persistent or uncontrolled. 2) Un co-operative child or parents not motivated. 3) Non ambulatory or severe cases of hip and knee flexion deformity. 4) Significant skin lesion or allergy to electrodes. 5) GMFCS level 4 and 5. 6) Cardiovascular diseases.

Design outcomes

Primary

MeasureTime frame
The gait parameters (such as speed, cadence, step length etc.)Timepoint: Will be performed at weeks 0,4,8 and 12.

Secondary

MeasureTime frame
Other outcomes like physiological cost index(PCI), functional improvement measured using a standard Gross Motor Function Measure-GMFM 66 scale), and electromyographyTimepoint: Will be performed at weeks 0,4,8 and 12.

Countries

India

Contacts

Public ContactDr P K Lenka

Indian Institute of Technology (IIT)-Kharagpur

arbik483@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026